Results - Announcements
Sai Parenterals Ltd share price inched up 2.80% to Rs 521.0 after the company's net profit surged by 32.70% to Rs 10.51 crore, while revenue from operations improved marginally 9.09% to Rs 194.92 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.66 lakh crore, rising 4.55%. It has marginally improved by 4.66% over last one week and moved up slightly by 1.10% in last one month while the market capitalization of Sai Parenterals Ltd has gained 14.47% and 1.93% in the same period respectively.
Profit before tax (PBT) of Sai Parenterals Ltd stood at Rs 9.89 crore in Q3 FY26, easing 8.09% year-on-year, and gaining 1.02% quarter-on-quarter. EBITDA came in at Rs 37 crore, surging by 261.94% YoY and jumping 84.63% sequentially.
Total expenses went up by 10.11% to Rs 179.77 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 82.24 crore, slumping by 29.18% YoY, while employee benefits expense was at Rs 12.86 crore, registering a growth of 11.44% YoY.
For the TTM ended FY26, revenue from operations witnessed a strong growth of 133.58% to Rs 381.0 crore, while net profit eased 1.18% to Rs 14.26 crore, compared to previous TTM. EBITDA jumped by 4639% to Rs 30.18 crore, and PBT tanked by 40.08% to Rs 11.93 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 93.05 crore in FY26, as against Rs 33.15 crore in FY25.
Sai Parenterals Ltd rallied 28.20% in last one year, significantly outperforming the benchmark BSE Sensex which has reduced by 11.78% during the same period.